Michelle Magee

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

2022 National Standards for Diabetes Self-Management Education and Support

Jody Davis, Amy Hess Fischl, Joni Beck et al. · The Science of Diabetes Self-Management and Care · 2022 · 159 citations

Medicine, Health Education, Medical Education +14

Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

Christine G. Lee, Brandy M. Heckman‐Stoddard, Dana Dabelea et al. · Diabetes Care · 2021 · 99 citations · Full text

Medicine, Pharmacotherapy, Preventive Medicine +17

SYNTAX Score and Long-Term Outcomes

Fumiaki Ikeno, Maria M. Brooks, Kaori Nakagawa et al. · Journal of the American College of Cardiology · 2017 · 86 citations

Language Studies, Speech-language Pathology, Syntax +9